Search

Search Constraints

You searched for: Author/Creator Ashton, Nicholas

Search Results

1. The SCD‐Well randomized controlled trial: Effects of a mindfulness‐based intervention versus health education on mental health in patients with subjective cognitive decline (SCD). Issue 1 (28th November 2018)

2. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort. Issue 6 (8th May 2019)

3. P3‐113: NOVEL CANDIDATE BLOOD PROTEOME MARKERS OF ALZHEIMER'S DISEASE BRAIN AMYLOID BURDEN: A MULTIPLEX TMT‐LC/MS‐MS DISCOVERY APPROACH. (1st July 2014)

4. P3‐108: DISCOVERY AND VALIDATION OF PLASMA BIOMARKERS RELATING TO CSF MEASURES OF ALZHEIMER'S DISEASE PATHOLOGY. (1st July 2014)

5. Feasibility of heating metal implants with alternating magnetic fields (AMF) in scaled up models. (31st December 2022)

6. Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration. Issue 9 (1st July 2020)

7. Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study. Issue 1 (10th August 2022)

9. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study. Issue 7 (July 2021)

10. Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease. Issue 4 (15th September 2022)